INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
7.77
-0.30 (-3.72%)
At close: Apr 3, 2025, 4:00 PM
7.74
-0.03 (-0.44%)
Pre-market: Apr 4, 2025, 4:05 AM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $178.17 million as of April 3, 2025. Its market cap has decreased by -10.29% in one year.
Market Cap
178.17M
Enterprise Value
157.63M
1-Year Change
-10.29%
Ranking
Category
Stock Price
$7.77
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $178.17M, an increase of 128.94%. That is a compound annual growth rate of 14.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.75B |
| UnitedHealth Group | 478.58B |
| Johnson & Johnson | 374.39B |
| AbbVie | 362.98B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 228.81B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.75B |